Skip to main content
Erschienen in: Clinical Autonomic Research 1/2007

01.02.2007 | RESEARCH ARTICLE

Vasovagal syncope in patients with reduced left ventricular function

verfasst von: Christopher M. Stanton, MD, Phillip A. Low, MD, David O. Hodge, Win-Kuang Shen, MD

Erschienen in: Clinical Autonomic Research | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

Vasovagal syncope (VVS) is mediated by arterial mechanoreceptors, resulting in reflexive changes in heart rate and vascular tone. The Bezold–Jarisch reflex was originally described as enhanced contraction and activation of left ventricular mechanoreceptors, but later studies implicated other triggers, including coronary, carotid, and cerebral arterial mechanoreceptors. VVS is uncommon in patients with left ventricular dysfunction. We hypothesized that VVS could occur in this subset and examined patient characteristics and hemodynamic responses during tilt table testing. From 1996 through 1998, 128 consecutive patients with ejection fraction <40% underwent tilt table testing (70°, 45 min). A total of 15 patients (11.7%) had a positive neurocardiogenic response thought to be the cause of syncope. Clinical data and hemodynamic responses were reviewed. Mean patient age (±SEM) was 70.1 ± 12.2 years. Nine patients were male. Mean ejection fraction was 27.7% ± 7.1%. Thirteen had electrophysiologic studies with normal findings or abnormal findings insufficient to account for syncope. Hemodynamic analysis of 14 patients who had a vasovagal response during passive tilt table testing showed a mean time to positive response of 17.6 ± 12.7 min. Cardioinhibitory responses (pauses >3 sec or heart rate < 40 beats/min for ≥10 sec) were not observed. Five responses were classified as mixed type (>10% decrease in heart rate without a cardioinhibitory response) and 9 as vasodepressor type (≤10% decrease in heart rate). VVS occurs in patients who have clinically significant left ventricular dysfunction. Although this study had a small cohort size, the predominantly vasodepressor response without a cardioinhibitory component warrants further investigation into mechanisms of VVS in these patients.
Literatur
2.
Zurück zum Zitat Ammirati F, Colivicchi F, Santini M, Syncope Diagnosis and Treatment Study Investigators (2001) Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. Circulation 104:52–57PubMed Ammirati F, Colivicchi F, Santini M, Syncope Diagnosis and Treatment Study Investigators (2001) Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. Circulation 104:52–57PubMed
3.
Zurück zum Zitat Barraco RA, Janusz CJ, Polasek PM, Parizon M, Roberts PA (1988) Cardiovascular effects of microinjection of adenosine into the nucleus tractus solitarius. Brain Res Bull 20:129–132PubMedCrossRef Barraco RA, Janusz CJ, Polasek PM, Parizon M, Roberts PA (1988) Cardiovascular effects of microinjection of adenosine into the nucleus tractus solitarius. Brain Res Bull 20:129–132PubMedCrossRef
4.
Zurück zum Zitat Connolly SJ, Sheldon R, Roberts RS, Gent M (1999) The North American Vasovagal Pacemaker Study (VPS): a randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 33:16–20PubMedCrossRef Connolly SJ, Sheldon R, Roberts RS, Gent M (1999) The North American Vasovagal Pacemaker Study (VPS): a randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 33:16–20PubMedCrossRef
5.
Zurück zum Zitat Connolly SJ, Sheldon R, Thorpe KE, Roberts RS, Ellenbogen KA, Wilkoff BL, Morillo C, Gent M, VPS II Investigators (2003) Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA 289:2224–2229PubMedCrossRef Connolly SJ, Sheldon R, Thorpe KE, Roberts RS, Ellenbogen KA, Wilkoff BL, Morillo C, Gent M, VPS II Investigators (2003) Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA 289:2224–2229PubMedCrossRef
6.
Zurück zum Zitat Del Rosso A, Alboni P, Brignole M, Menozzi C, Raviele A (2005) Relation of clinical presentation of syncope to the age of patients. Am J Cardiol 96:1431–1435. Epub 2005 Sep 27PubMedCrossRef Del Rosso A, Alboni P, Brignole M, Menozzi C, Raviele A (2005) Relation of clinical presentation of syncope to the age of patients. Am J Cardiol 96:1431–1435. Epub 2005 Sep 27PubMedCrossRef
7.
Zurück zum Zitat Evans RG, Ludbrook J, Van Leeuwen AF (1989) Role of central opiate receptor subtypes in the circulatory responses of awake rabbits to graded caval occlusions. J Physiol 419:15–31PubMed Evans RG, Ludbrook J, Van Leeuwen AF (1989) Role of central opiate receptor subtypes in the circulatory responses of awake rabbits to graded caval occlusions. J Physiol 419:15–31PubMed
8.
Zurück zum Zitat Furlan R, Piazza S, Dell’Orto S, Barbic F, Bianchi A, Mainardi L, Cerutti S, Pagani M, Malliani A (1998) Cardiac autonomic patterns preceding occasional vasovagal reactions in healthy humans. Circulation 98:1756–1761PubMed Furlan R, Piazza S, Dell’Orto S, Barbic F, Bianchi A, Mainardi L, Cerutti S, Pagani M, Malliani A (1998) Cardiac autonomic patterns preceding occasional vasovagal reactions in healthy humans. Circulation 98:1756–1761PubMed
9.
Zurück zum Zitat Grubb BP, Gerard G, Roush K, Temesy-Armos P, Montford P, Elliott L, Hahn H, Brewster P (1991) Cerebral vasoconstriction during head-upright tilt-induced vasovagal syncope: a paradoxic and unexpected response. Circulation 84:1157–1164PubMed Grubb BP, Gerard G, Roush K, Temesy-Armos P, Montford P, Elliott L, Hahn H, Brewster P (1991) Cerebral vasoconstriction during head-upright tilt-induced vasovagal syncope: a paradoxic and unexpected response. Circulation 84:1157–1164PubMed
10.
Zurück zum Zitat Grubb BP, Wolfe DA, Samoil D, Temesy-Armos P, Hahn H, Elliott L (1993) Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope. Pacing Clin Electrophysiol 16:458–464PubMedCrossRef Grubb BP, Wolfe DA, Samoil D, Temesy-Armos P, Hahn H, Elliott L (1993) Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope. Pacing Clin Electrophysiol 16:458–464PubMedCrossRef
11.
Zurück zum Zitat Jarisch A, Richter H (1939) Die afferenten Bahnen des Veratrineffektes in den Herznerven. Arch Exper Path Pharmakol 193:355–371CrossRef Jarisch A, Richter H (1939) Die afferenten Bahnen des Veratrineffektes in den Herznerven. Arch Exper Path Pharmakol 193:355–371CrossRef
12.
Zurück zum Zitat Kapoor WN (1990) Evaluation and outcome of patients with syncope. Medicine (Baltimore) 69:160–175 Kapoor WN (1990) Evaluation and outcome of patients with syncope. Medicine (Baltimore) 69:160–175
13.
Zurück zum Zitat Kapoor WN, Smith MA, Miller NL (1994) Upright tilt testing in evaluating syncope: a comprehensive literature review. Am J Med 97:78–88PubMedCrossRef Kapoor WN, Smith MA, Miller NL (1994) Upright tilt testing in evaluating syncope: a comprehensive literature review. Am J Med 97:78–88PubMedCrossRef
14.
Zurück zum Zitat Morita H, Nishida Y, Motochigawa H, Uemura N, Hosomi H, Vatner SF (1988) Opiate receptor-mediated decrease in renal nerve activity during hypotensive hemorrhage in conscious rabbits. Circ Res 63:165–172PubMed Morita H, Nishida Y, Motochigawa H, Uemura N, Hosomi H, Vatner SF (1988) Opiate receptor-mediated decrease in renal nerve activity during hypotensive hemorrhage in conscious rabbits. Circ Res 63:165–172PubMed
15.
Zurück zum Zitat Mosqueda-Garcia R, Furlan R, Fernandez-Violante R, Desai T, Snell M, Jarai Z, Ananthram V, Robertson RM, Robertson D (1997) Sympathetic and baroreceptor reflex function in neurally mediated syncope evoked by tilt. J Clin Invest 99:2736–2744PubMedCrossRef Mosqueda-Garcia R, Furlan R, Fernandez-Violante R, Desai T, Snell M, Jarai Z, Ananthram V, Robertson RM, Robertson D (1997) Sympathetic and baroreceptor reflex function in neurally mediated syncope evoked by tilt. J Clin Invest 99:2736–2744PubMedCrossRef
16.
Zurück zum Zitat Mosqueda-Garcia R, Furlan R, Tank J, Fernandez-Violante R (2000) The elusive pathophysiology of neurally mediated syncope. Circulation 102:2898–2906PubMed Mosqueda-Garcia R, Furlan R, Tank J, Fernandez-Violante R (2000) The elusive pathophysiology of neurally mediated syncope. Circulation 102:2898–2906PubMed
17.
Zurück zum Zitat Oberg B, Thoren P (1972) Increased activity in left ventricular receptors during hemorrhage or occlusion of caval veins in the cat: a possible cause of the vaso-vagal reaction. Acta Physiol Scand 85:164–173PubMedCrossRef Oberg B, Thoren P (1972) Increased activity in left ventricular receptors during hemorrhage or occlusion of caval veins in the cat: a possible cause of the vaso-vagal reaction. Acta Physiol Scand 85:164–173PubMedCrossRef
18.
Zurück zum Zitat Perna GP, Ficola U, Salvatori MP, Stanislao M, Vigna C, Villella A, Russo A, Fanelli R, Paleani Vettori PG, Loperfido F (1990) Increase of plasma beta endorphins in vasodepressor syncope. Am J Cardiol 65:929–930PubMedCrossRef Perna GP, Ficola U, Salvatori MP, Stanislao M, Vigna C, Villella A, Russo A, Fanelli R, Paleani Vettori PG, Loperfido F (1990) Increase of plasma beta endorphins in vasodepressor syncope. Am J Cardiol 65:929–930PubMedCrossRef
19.
Zurück zum Zitat Savage DD, Corwin L, McGee DL, Kannel WB, Wolf PA (1985) Epidemiologic features of isolated syncope: the Framingham Study. Stroke 16:626–629PubMed Savage DD, Corwin L, McGee DL, Kannel WB, Wolf PA (1985) Epidemiologic features of isolated syncope: the Framingham Study. Stroke 16:626–629PubMed
20.
Zurück zum Zitat Scherrer U, Vissing S, Morgan BJ, Hanson P, Victor RG (1990) Vasovagal syncope after infusion of a vasodilator in a heart-transplant recipient. N Engl J Med 322: 602–604PubMedCrossRef Scherrer U, Vissing S, Morgan BJ, Hanson P, Victor RG (1990) Vasovagal syncope after infusion of a vasodilator in a heart-transplant recipient. N Engl J Med 322: 602–604PubMedCrossRef
21.
Zurück zum Zitat Sheldon R, Rose S, Flanagan P, Koshman ML, Killam S (1996) Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation 93:973–981PubMed Sheldon R, Rose S, Flanagan P, Koshman ML, Killam S (1996) Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation 93:973–981PubMed
22.
Zurück zum Zitat Shen WK, Hammill SC, Munger TM, Stanton MS, Packer DL, Osborn MJ, Wood DL, Bailey KR, Low PA, Gersh BJ (1996) Adenosine: potential modulator for vasovagal syncope. J Am Coll Cardiol 28:146–154PubMedCrossRef Shen WK, Hammill SC, Munger TM, Stanton MS, Packer DL, Osborn MJ, Wood DL, Bailey KR, Low PA, Gersh BJ (1996) Adenosine: potential modulator for vasovagal syncope. J Am Coll Cardiol 28:146–154PubMedCrossRef
23.
Zurück zum Zitat Shen W-K, Gersh BJ (1997) Fainting: approach to management. In: Low PA (ed) Clinical autonomic disorders: evaluation and management. 2nd ed. Lippincott-Raven, Philadelphia, pp 649–679 Shen W-K, Gersh BJ (1997) Fainting: approach to management. In: Low PA (ed) Clinical autonomic disorders: evaluation and management. 2nd ed. Lippincott-Raven, Philadelphia, pp 649–679
24.
Zurück zum Zitat Sutton R, Brignole M, Menozzi C, Raviele A, Alboni P, Giani P, Moya A, The Vasovagal Syncope International Study (VASIS) Investigators (2000) Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: pacemaker versus no therapy: a multicenter randomized study. Circulation 102:294–299PubMed Sutton R, Brignole M, Menozzi C, Raviele A, Alboni P, Giani P, Moya A, The Vasovagal Syncope International Study (VASIS) Investigators (2000) Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: pacemaker versus no therapy: a multicenter randomized study. Circulation 102:294–299PubMed
25.
Zurück zum Zitat von Bezold A, Hirt L (1867) Uber die physiologischen Wirkungen des essigsauren veratrins: untersuchungen aus dem physiologischen Laboratorium. Wurzburg 1:75–156 von Bezold A, Hirt L (1867) Uber die physiologischen Wirkungen des essigsauren veratrins: untersuchungen aus dem physiologischen Laboratorium. Wurzburg 1:75–156
26.
Zurück zum Zitat Wallin BG, Sundlof G (1982) Sympathetic outflow to muscles during vasovagal syncope. J Auton Nerv Syst 6:287–291PubMedCrossRef Wallin BG, Sundlof G (1982) Sympathetic outflow to muscles during vasovagal syncope. J Auton Nerv Syst 6:287–291PubMedCrossRef
27.
Zurück zum Zitat Waxman MB, Cameron DA, Wald RW (1993) Role of ventricular vagal afferents in the vasovagal reaction. J Am Coll Cardiol 21:1138–1141PubMedCrossRef Waxman MB, Cameron DA, Wald RW (1993) Role of ventricular vagal afferents in the vasovagal reaction. J Am Coll Cardiol 21:1138–1141PubMedCrossRef
28.
Zurück zum Zitat Wright C, Drinkhill MJ, Hainsworth R (2000) Reflex effects of independent stimulation of coronary and left ventricular mechanoreceptors in anaesthetised dogs. J Physiol 528:349–358PubMedCrossRef Wright C, Drinkhill MJ, Hainsworth R (2000) Reflex effects of independent stimulation of coronary and left ventricular mechanoreceptors in anaesthetised dogs. J Physiol 528:349–358PubMedCrossRef
Metadaten
Titel
Vasovagal syncope in patients with reduced left ventricular function
verfasst von
Christopher M. Stanton, MD
Phillip A. Low, MD
David O. Hodge
Win-Kuang Shen, MD
Publikationsdatum
01.02.2007
Erschienen in
Clinical Autonomic Research / Ausgabe 1/2007
Print ISSN: 0959-9851
Elektronische ISSN: 1619-1560
DOI
https://doi.org/10.1007/s10286-006-0386-8

Weitere Artikel der Ausgabe 1/2007

Clinical Autonomic Research 1/2007 Zur Ausgabe

Neu in den Fachgebieten Neurologie und Psychiatrie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.